Company profile for Centogene

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

CENTOGENE is one of the largest genetic biotech companies in rare hereditary diseases, and one of the global leaders in genetic diagnostic analyses of rare inherited disorders. Our solutions go much beyond laboratory testing and medical interpretation, leveraging our biobank, our global clinical network and deep medical expertise and our proprietary CentoCard® based sample logistics. But our state-of-the-art genetic and bioma...
CENTOGENE is one of the largest genetic biotech companies in rare hereditary diseases, and one of the global leaders in genetic diagnostic analyses of rare inherited disorders. Our solutions go much beyond laboratory testing and medical interpretation, leveraging our biobank, our global clinical network and deep medical expertise and our proprietary CentoCard® based sample logistics. But our state-of-the-art genetic and biomarker testing remains the core of what we do. Learn what we do in our operations, and what our global quality standards and accreditations are.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Germany
Address
Address
Am Strande 7, 18055 Rostock
Telephone
Telephone
+49 (0) 381 - 80113 416
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com//news-release/2025/03/12/3041199/0/en/CENTOGENE-Closes-Strategic-Transaction-with-Private-Equity-Group-Charme-Capital-Partners.html

GLOBENEWSWIRE
12 Mar 2025

https://www.globenewswire.com/news-release/2024/12/05/2991998/0/en/CENTOGENE-Announces-Voting-Results-of-Extraordinary-General-Meeting.html

GLOBENEWSWIRE
04 Dec 2024

https://www.globenewswire.com/news-release/2024/11/13/2980060/0/en/CENTOGENE-Signs-Strategic-Transaction-With-Private-Equity-Group-Charme-Capital-Partners.html

GLOBENEWSWIRE
13 Nov 2024

https://www.globenewswire.com/news-release/2024/09/25/2952924/0/en/CENTOGENE-Data-on-Novel-Genetic-Risk-Factor-for-Parkinson-s-Disease-in-The-Lancet-Neurology.html

GLOBENEWSWIRE
25 Sep 2024

https://www.globenewswire.com/news-release/2024/08/07/2926492/0/en/CENTOGENE-Receives-Delisting-Notice-From-Nasdaq.html

GLOBENEWSWIRE
07 Aug 2024

https://www.globenewswire.com/news-release/2024/08/01/2923257/0/en/CENTOGENE-Publication-in-Brain-Journal-Reveals-15-of-Parkinson-s-Disease-Cases-Are-Linked-to-Genetic-Factors.html

GLOBENEWSWIRE
01 Aug 2024

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty